Detalhe da pesquisa
1.
Peripheral T-cell lymphoma with a T follicular-helper phenotype: A different entity? Results of the Spanish Real-T study.
Br J Haematol
; 203(2): 182-193, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37386897
2.
Anti-CD30 antibody-drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives.
Ann Hematol
; 102(1): 13-29, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36512081
3.
Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma.
Ann Hematol
; 102(2): 429-437, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370191
4.
A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 136(21): 2401-2409, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730586
5.
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experience.
Br J Haematol
; 192(6): 1020-1025, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445250
6.
Clinical and pathological characteristics of peripheral T-cell lymphomas in a Spanish population: a retrospective study.
Br J Haematol
; 192(1): 82-99, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32426847
7.
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
Ann Hematol
; 100(4): 1023-1029, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367180
8.
Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance.
Clin Infect Dis
; 70(6): 1068-1074, 2020 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321410
9.
Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain.
Biol Blood Marrow Transplant
; 26(8): 1534-1542, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068094
10.
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Lancet
; 393(10168): 229-240, 2019 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30522922
11.
Long-term outcome comparing histological grades of follicular lymphoma patients treated with immunochemotherapy as first-line therapy: A retrospective analysis from two institutions.
Eur J Haematol
; 104(3): 198-206, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769545
12.
m7FLIPI and targeted sequencing in high-risk follicular lymphoma.
Hematol Oncol
; 37(5): 564-568, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31475375
13.
Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.
Blood
; 137(7): 994-999, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915956
14.
Comment on: Brentuximab vedotin-related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity?
Pediatr Blood Cancer
; 70(11): e30527, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365120
15.
Long-term safety and outcome of fludarabine, cyclophosphamide and mitoxantrone (FCM) regimen in previously untreated patients with advanced follicular lymphoma: 12 years follow-up of a phase 2 trial.
Ann Hematol
; 96(4): 639-646, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28101592
16.
Phase II trial of ofatumumab plus ESHAP (O-ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.
Br J Haematol
; 174(6): 859-67, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185197
17.
Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.
Acta Haematol
; 136(2): 76-84, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27188649
18.
Systemic rituximab for the treatment of the indolent forms of primary cutaneous B-cell lymphomas: Data from the Spanish Primary Cutaneous Lymphoma Registry.
J Am Acad Dermatol
; 83(5): 1535-1538, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682893
19.
Long-term results of a phase 2 study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma.
Blood
; 130(15): 1772-1774, 2017 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801448
20.
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.
Support Care Cancer
; 22(3): 603-10, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24170166